Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Drug-eluting coronary stents--promise and uncertainty.

Curfman GD, Morrissey S, Jarcho JA, Drazen JM.

N Engl J Med. 2007 Mar 8;356(10):1059-60. No abstract available.

2.

Drug-eluting stents is their future as bright as their past?

Kastrati A, Schömig A.

J Am Coll Cardiol. 2007 Jul 10;50(2):146-8. No abstract available.

3.

Unanswered questions--drug-eluting stents and the risk of late thrombosis.

Maisel WH.

N Engl J Med. 2007 Mar 8;356(10):981-4. No abstract available.

4.

Debating the risks of drug-eluting stents.

Shuchman M.

N Engl J Med. 2007 Jan 25;356(4):325-8. No abstract available.

PMID:
17251527
6.

Stent thrombosis redux--the FDA perspective.

Farb A, Boam AB.

N Engl J Med. 2007 Mar 8;356(10):984-7. No abstract available.

7.

Stent thrombosis in randomized clinical trials of drug-eluting stents.

Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE.

N Engl J Med. 2007 Mar 8;356(10):1020-9.

8.

Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.

Jaffe R, Strauss BH.

J Am Coll Cardiol. 2007 Jul 10;50(2):119-27. Review.

9.

Bare-metal versus drug-eluting coronary stents.

Agostoni P, Vermeersch P.

N Engl J Med. 2008 Jun 5;358(23):2516-7; author reply 2517-8. No abstract available.

PMID:
18536096
10.

Problems with drug-eluting coronary stents--the FDA perspective.

Muni NI, Gross TP.

N Engl J Med. 2004 Oct 14;351(16):1593-5. No abstract available.

PMID:
15483274
11.

Late thrombosis a concern with drug-eluting stents.

Leon MB.

J Interv Cardiol. 2007 Feb;20(1):26-9. Review. No abstract available.

PMID:
17300394
12.

Concerns over safety of drug-eluting stents.

[No authors listed]

Expert Rev Med Devices. 2006 Nov;3(6):689-90. No abstract available.

PMID:
17280532
13.

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

N Engl J Med. 2007 Mar 8;356(10):998-1008.

14.

Trading restenosis for thrombosis? New questions about drug-eluting stents.

Shuchman M.

N Engl J Med. 2006 Nov 9;355(19):1949-52. No abstract available.

PMID:
17093244
15.

Drug-eluting coronary stents: what are the risks?

Kersten JR, Fleisher LA.

Anesthesiology. 2007 May;106(5):898-900. No abstract available.

PMID:
17457119
16.

Thrombosis and drug-eluting stents: an objective appraisal.

Holmes DR Jr, Kereiakes DJ, Laskey WK, Colombo A, Ellis SG, Henry TD, Popma JJ, Serruys PW, Kimura T, Williams DO, Windecker S, Krucoff MW.

J Am Coll Cardiol. 2007 Jul 10;50(2):109-18. Review.

17.

Drug-eluting stents: some bare facts.

Eisenberg MJ.

Lancet. 2004 Oct 23-29;364(9444):1466-7. No abstract available.

PMID:
15500872
18.

Stent thrombosis in the era of drug eluting stents.

Kawaguchi R, Angiolillo DJ, Futamatsu H, Suzuki N, Bass TA, Costa MA.

Minerva Cardioangiol. 2007 Apr;55(2):199-211. Review.

PMID:
17342038
19.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A.

N Engl J Med. 2007 Mar 8;356(10):1030-9.

20.

Late thrombosis associated with drug-eluting stents.

Derghazarian S, Eisenberg MJ.

Am Heart Hosp J. 2005 Summer;3(3):203-4. Review. No abstract available.

PMID:
16106143
Items per page

Supplemental Content

Support Center